AKTX
Akari Therapeutics PLC
NASDAQ: AKTX · HEALTHCARE · BIOTECHNOLOGY
$5.35
+2.10% today
Updated 2026-04-30
Market cap
$6.00M
P/E ratio
0.00
P/S ratio
478,368.50x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$3 – $59
Volume
0.3M
Akari Therapeutics PLC (AKTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $0.00 | $0.00 | $10159.00 | $39772.00 | $0.00 | $35848.00 | $19205.00 | $8907.00 | $4126.00 | $3708.00 | $4000.00 | $13999.00 | — |
| Gross profit | — | — | — | $0.00 | $0.00 | $-10159.00 | $-39772.00 | $0.00 | $-35848.00 | $-19205.00 | $-8907.00 | $-4126.00 | $-3708.00 | $-4000.00 | $-13999.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $247000.00 | $841000.00 | $1.02M | $1.28M | $6.42M | $5.80M | $17.31M | $23.29M | $15.59M | $16.65M | $12.19M | $9.13M | $9.56M | $8.02M | $6.98M | $2.81M |
| SG&A | $545000.00 | $1.41M | $734000.00 | $2.33M | $3.76M | $5.50M | $9.94M | $11.67M | $10.90M | $8.22M | $9.16M | $8.08M | $13.53M | $11.36M | $9.66M | $9.28M |
| Operating income | $-792000.00 | $-2.25M | $-3.67M | $-3.61M | $-10.18M | $-30.58M | $-27.25M | $-34.96M | $-19.99M | $-24.87M | $-17.98M | $-17.21M | $-23.09M | $-16.81M | $-21.64M | $-17.27M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-792000.00 | $-2.12M | $-3.36M | $-3.42M | $-10.19M | $-19.28M | $-27.25M | $-37.18M | $-16.43M | $-24.73M | $-17.97M | $-17.21M | $-23.08M | $-16.80M | $-19.53M | $-17.35M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-792000.00 | $-1.98M | $-3.36M | $-3.42M | $-10.20M | $-19.29M | $-27.29M | $-34.96M | $-16.47M | $-24.75M | $-17.98M | $-17.21M | $-23.09M | $-16.81M | $-19.55M | — |
| Interest expense | $5000.00 | $0.00 | $1.04M | $202000.00 | $0.00 | $3.05M | $9.15M | $2.40M | $82000.00 | $267000.00 | $205000.00 | $210101.00 | $5.34M | $0.00 | $244000.00 | $949000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-675000.00 | $-2.12M | $-1.44M | $-3.62M | $-9.65M | $-45.32M | $-18.14M | $-27.92M | $-19.95M | $-16.85M | $-17.08M | $-17.42M | $-17.75M | $-10.01M | $-19.79M | $-17.30M |
| Net income growth (YoY) | — | -213.9% | +32.3% | -152.3% | -166.5% | -369.7% | +60.0% | -53.9% | +28.6% | +15.6% | -1.4% | -2.0% | -1.9% | +43.6% | -97.8% | +12.6% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |